Pricing Log in Create free account

ADARx Pharmaceuticals, Inc. (ADRX) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

ADARx Pharmaceuticals, Inc. and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.5B and $1.5B).

Valuation

Metric ADRX NBTX Biotechnology median
P/E — n/m 10.60
P/S — 6,111.93 9.40
P/B — n/m 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 5,356.43 9.02
Earnings yield — (10.85%) (32.88%)
Free cash flow yield — (13.68%) (23.13%)

Profitability

Metric ADRX NBTX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — 0.00% (51.96%)
Return on assets — 0.00% (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric ADRX NBTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) — 63.46% 29.88%
Revenue growth, 5-year CAGR — 66.64% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADRX NBTX Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 1.44 4.97
Net debt to EBITDA — 5.66 1.01

Dividend

Metric ADRX NBTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADRX NBTX Biotechnology median
Market cap 1.47b 1.53b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack